Max Robotics — Global Service Robot Directory + US Certification

About

Kristen Rodgers is a translational researcher whose work focuses on the development of non-invasive liquid biopsy biomarkers for early cancer detection, with a particular emphasis on pulmonary oncology. Her most cited study, published in 2021, introduced a groundbreaking, cost-effective test utilizing plasma protein functional effector sncRNAs (pfeRNAs) to differentiate between benign, suspicious, and malignant pulmonary nodules. This work addresses a critical clinical challenge: the need for definitive, non-invasive intervention guidance in patients with early-stage lung cancers. By demonstrating that pfeRNAs can serve as reliable biomarkers, Rodgers’ research offers a promising alternative to invasive procedures, potentially reducing unnecessary surgeries and improving patient outcomes. With 9 citations, this study has already garnered attention for its practical implications in precision oncology. Rodgers’ contributions are particularly notable for bridging the gap between molecular biology and clinical application, providing a scalable solution that could transform lung cancer screening and diagnosis. Her work underscores the power of leveraging small non-coding RNAs in plasma to achieve high diagnostic accuracy, positioning her as an emerging leader in the field of cancer biomarker discovery.